Dec. 19, 2019
ISCHEMIA: Early intervention vs. conservative therapy can improve angina symptoms, quality of life for patients with SIHD and anginaResearchers in “Results for the ISCHEMIA Trials: To Intervene or Not To Intervene” Late-Breaking Science session during Scientific Sessions found Initial invasive therapy compared to optimal medical therapy in patients with stable ischemia heart disease and moderate-severe ischemia did not reduce the risk for cardiovascular events. Read More- New agents, targets becoming part of lipid managementHigh-dose statins, ezetimibe and PCSK inhibition are not the final word in lowering lipids. During a Late-Breaking Science session last month, investigators revealed new findings and approaches to manage lipids. Read More
Trials’ results suggest outside-the-box approaches to reduce CVD riskInvestigators in four trials revealed surprising findings on novel approaches to reduce CVD risk during their Late-Breaking Science session at Scientific Sessions. The glucose-lowering drug dapagliflozin may benefit heart failure patients without diabetes. Read More
Results inform management of severe aortic stenosisResearchers in Late-Breaking Science sessions during Scientific Sessions presented the latest findings on optimal timing of surgery for asymptomatic severe aortic stenosis, best prosthetic valve design and whether anticoagulation is efficacious and safe for patients after TAVR without indication for anticoagulation. Read More
Trials may change outlook on interventional management for ACSIn a Late-Breaking Clinical Trial session during Scientific Sessions, investigators exploring interventional management for acute coronary syndrome patients found Ticagrelor alone was as effective as ticagrelor plus aspirin in reducing ischemic events while reducing bleeding risk in a subgroup of high-risk patients after percutaneous coronary intervention for ACS. Read More
Drug combination may reduce CV mortality in HF patients across the ejection fraction spectrumResearchers in Late-Breaking Science sessions during Scientific Sessions presented the pooled PARAGON-HF and PARADIGM-HF analysis and the latest results on gender differences and response to treatment in heart failure patients with preserved ejection fraction, a drug that improves exercise performance with Fontan circulation and how older HF patients tolerated dapagliflozin and patients’ reported quality of life Read More
Dec. 12, 2019
CONNER PRESIDENTIAL LECTURE: AHA president emphasizes evidence matters, diversityAHA President Robert Harrington used his Conner Presidential Address at Scientific Sessions to spotlight the two pillars of his career: clinical trials and supporting the next generation of researchers. He titled his speech “Evidence Matters,” a phrase that was a drumbeat throughout his presentation during day two of the organization’s flagship conference. Read More
AHA tackles youth vaping crisis with massive new initiativeThe American Heart Association is fighting for the country’s young people and against the vaping epidemic by funding millions in new nicotine research, working to strengthen laws and policies nationwide, and exposing the e-cigarette industry’s lies. The effort announced at a press conference during Scientific Sessions takes on this public health crisis in bold new ways. Read More
NEPAL: Echocardiographic screening of children may reduce burden of rheumatic heart diseaseEchocardiographic screening of children for subclinical rheumatic heart disease and secondary antibiotic prevention in affected children may reduce the burden in endemic regions, according to an abstract presented at Scientific Sessions. In the study, researchers conducted a cluster-randomized comparison of echocardiographic screening for RHD versus a control group among schoolchildren in eastern Nepal. Read More
Home visits helped reduce blood pressure in rural Bangladesh, Pakistan, Sri LankaHome visits by government community health workers led to reductions in systolic blood pressure in rural Bangladesh, Pakistan and Sri Lanka, according to a study presented in a Late-Breaking Science session during Scientific Sessions. The visits were part of a multicomponent intervention integrated with existing health systems. Read More
PRESIDENTIAL SESSION: AHA takes strong stand against vapingThe Scientific Sessions Presidential Session concluded with a look back at the AHA’s many successes over the past year and a standing ovation for one determined, young woman working to end the teen vaping epidemic. AHA CEO Nancy Brown called 16-year-old Katelyn Quezada of Los Angeles to the stage, along with an army of Quezada’s supportive peers. The group, partnering with the AHA, released an open letter on Sunday denouncing the dangers of vaping. Read More
SCIENTIFIC SESSIONS KEYNOTE: Murat Sönmez, World Economic Forum tackle ethics, equity and access of big dataAgainst the historic backdrop of Philadelphia, Murat Sönmez charted the course for the future of big data while sharing important lessons from history. Sönmez, keynote speaker at the Scientific Sessions Presidential Session, is managing director of the World Economic Forum and head of its Centre for the Fourth Industrial Revolution Network.
Read More
IN MEMORIAM: CEO remembers Bernard Tyson for leaving health care ‘better than he found it’Bernard J. Tyson, a longtime supporter of the American Heart Association who helped shape the organization as a member of the Board of Directors and co-founder of the CEO Roundtable, was remembered during Scientific Sessions for his devotion to improving the health and well-being of all Americans. Tyson, the chairman and CEO of Kaiser Permanente, died in his sleep the previous Sunday. He was 60. Read More- Mark your calendar for Scientific Sessions 2020Look for more cutting-edge Late-Breaking Science in 2020. Mark your calendar and join us Nov. 14-16 in Dallas, Texas. Read More